General
Preferred name
NU2058
Synonyms
NU 2058 ()
O6-(Cyclohexylmethyl)guanine ()
O(6)-Cyclohexylmethylguanine ()
6-O-Cyclohexylmethyl Guanine ()
NU 2058 ()
P&D ID
PD008359
CAS
161058-83-9
Tags
available
drug candidate
Drug indication
Discovery agent
Drug Status
experimental
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Cdk1 and cdk2 inhibitor (Tocriscreen Plus)
DESCRIPTION MK2 inhibitor; also cdk inhibitor; potently inhibits cdk9 (Tocris Bioactive Compound Library)
DESCRIPTION NU2058 is a potent CDK inhibitor. which has CDK2 IC(50)=17 microM and CDK1 IC(50)=26 microM. (BOC Sciences Bioactive Compounds)
Cell lines
2
Organisms
0
Compound Sets
11
BOC Sciences Bioactive Compounds
nu2058-cas-161058-83-9-item-84-205677
Cayman Chemical Bioactives
21415
CDK inhibitor database (CDKiDB)
Drug Repurposing Hub
DrugBank
DB02407
DrugMAP
DMDIW08
MedChem Express Bioactive Compound Library
HY-19316
Selleckchem Bioactive Compound Library
nu2058
TargetMol Bioactive Compound Library
T3186
Tocris Bioactive Compound Library
3135
Tocriscreen Plus
3135
External IDs
30
Properties
(calculated by RDKit )
Molecular Weight
247.14
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
2
cLogP
1.89
TPSA
89.71
Fraction CSP3
0.58
Chiral centers
0.0
Largest ring
6.0
QED
0.86
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target Type
Enzymes
Pathway
Cell Cycle/Checkpoint
DNA Damage/DNA Repair
Cell Cycle/DNA Damage
Target
CDK1
CDK2
Topo II
CCNA2, CDK2
CDK
Primary Target
Cyclin-Dependent Protein Kinases
MOA
Inhibitor
cyclin D inhibitor
Source data